Association between ABCB1 Genotype and Seizure Outcome in Collies with Epilepsy

Journal of Veterinary Internal Medicine

Volumn 26, Issue 6, 2012, Pages 1358-1364

  Munana K R ^a   Nettifee Osborne, J A ^a   Bergman, R L ^a,c   Mealey, K L ^b  

^a NORTH CAROLINA STATE UNIVERSITY   (United States)

^b WASHINGTON STATE UNIVERSITY   (United States)

^c West Mountain Animal Hospital   (United States)

Author keywords

Antiepileptic drug; Canine; Drug resistance; MDR1; P glycoprotein

Indexed keywords

ANTICONVULSIVE AGENT; BROMIDE; MULTIDRUG RESISTANCE PROTEIN; PHENOBARBITAL;

ANIMAL; ANIMAL DISEASE; ARTICLE; DOG; DOG DISEASE; EPILEPSY; GENE EXPRESSION REGULATION; GENETIC PREDISPOSITION; GENETICS; GENOTYPE;

ANIMALS; ANTICONVULSANTS; BROMIDES; DOG DISEASES; DOGS; EPILEPSY; GENE EXPRESSION REGULATION; GENETIC PREDISPOSITION TO DISEASE; GENOTYPE; P-GLYCOPROTEIN; PHENOBARBITAL;

ANIMALIA; CANIS FAMILIARIS;

EID: 84869889645     PISSN: 08916640     EISSN: 19391676     Source Type: Journal    
DOI: 10.1111/j.1939-1676.2012.01006.x     Document Type: Article

References (45)

1. Cunningham JG, Farnbach GC. Inheritance and idiopathic canine epilepsy. J Am Anim Hosp Assoc 1988;24:421-424.
2. Oliver JE. Seizure disorders in companion animals. Comp Cont Ed Pract Vet 1980;2:77-85.
3. Lane SB, Bunch SE. Medical management of recurrent seizures in dogs and cats. J Vet Intern Med 1990;4:26-39.
4. Sander JW. Some aspects of prognosis in the epilepsies: A review. Epilepsia 1993;34:1007-1016.
5. Devinsky O. Patients with refractory seizures. N Engl J Med 1999;340:1565-1570.
6. Bateman SW, Parent JM. Clinical findings, treatment, and outcome of dogs with status epilepticus or cluster seizures: 156 cases (1990-1995). J Am Vet Med Assoc 1999;215:1463-1468.
7. Kwan P, Brodie MJ. Refractory epilepsy: Mechanisms and solutions. Expert Rev Neurother 2006;6:397-406.
8. Löscher W, Schmidt D. Modern antiepileptic drug development has failed to deliver: Ways out of the current dilemma. Epilepsia 2011;52:657-678.
9. Remy S, Beck H. Molecular and cellular mechanisms of pharmacoreistance in epilepsy. Brain 2006;129:18-35.
10. Sissodiya SM. Mechanisms of antiepileptic drug resistance. Curr Opin Neurol 2003;16:197-201.
11. Löscher W, Potschka H. Role of multidrug transporters in pharmacoresistance to antiepileptic drugs. J Pharmacol Exp Therap 2002;301:7-14.
12. Cordon-Cardo C, O'Brien JP, Casals D, et al. Multidrug-resistance gene (P-glycoprotein) is expressed by endothelial cells at blood-brain barrier sites. Proc Natl Acad Sci USA 1989;86:695-698.
13. Seegers U, Potschka H, Löscher W. Expression of the multidrug transporter P-glycoprotein in brain capillary endothelial cells and brain parenchyma of amygdala-kindled rats. Epilepsia 2002;43:675-684.
14. Rizzi M, Caccia S, Guiso G, et al. Limbic seizures induce P-glycoprotein in rodent brain: Functional implications for pharmacoresistance. J Neurosci 2002;22:5833-5839.
15. van Vliet E, Aronica E, Redeker S, et al. Selective and persistent upregulation of mdr1b mRNA and P-glycoprotein in the parahippocampal cortex of chronic epileptic rats. Epilepsy Res 2004;60:203-213.
16. Volk HA, Löscher W. Multidrug resistance in epilepsy: Rats with drug-resistant seizures exhibit enhanced brain expression of P-glycoprotein compared with rats with drug-responsive seizures. Brain 2005;128:1358-1368.
17. Tishler DM, Weinberg KI, Hinton DR, et al. MDR1 gene expression in brain of patients with medically intractable epilepsy. Epilepsia 1995;36:1-6.
18. Sissodiya SM, Thom M. Widespread upregulation of drug-resistance proteins in fatal human status epilepticus. Epilepsia 2003;44:261-264.
19. Dombrowski SM, Desai SY, Marroni M, et al. Overexpression of multiple drug resistance genes in endothelial cells from patients with refractory epilepsy. Epilepsia 2001;42:1501-1506.
20. Sisodiya SM, Lin WR, Harding BN, et al. Drug resistance in epilepsy: Expression of drug resistance proteins in common causes of refractory epilepsy. Brain 2002;125:22-31.
21. Aronica E, Gorter JA, Jansen GH, et al. Expression and cellular distribution of multidrug transporter proteins in two major causes of medically intractable epilepsy: Focal cortical dysplasia and glioneuronal tumors. Neuroscience 2003;118:417-429.
22. Aronica E, Gorter JA, Ramkema M, et al. Expression and cellular distribution of multidrug resistance-related proteins in the hippocampus of patients with mesial temporal lobe epilepsy. Epilepsia 2004;45:441-451.
23. Ak H, Ay B, Tanriverdi T, et al. Expression and cellular distribution of multidrug resistance-related proteins in patients with focal cortical dysplasia. Seizure 2007;16:493-503.
24. Kwan P, Li HM, Al-Jufairi E, et al. Association between temporal lobe P-glycoprotein expression and seizure recurrence after surgery for pharmacoresistant temporal lobe epilepsy. Neurobiol Dis 2010;39:192-197.
25. Pekcec A, Unkrüer B, Stein V, et al. Over-expression of P-glycoprotein in the canine brain following spontaneous status epilepticus. Epilepsy Res 2009;83:144-151.
26. Mealey KL, Bentjen SA, Gay JM, Cantor GH. Ivermectin sensitivity in Collies is associated with a deletion mutation of the mdr1 gene. Pharmacogenetics 2001;11:727-733.
27. Neff MW, Robertson KR, Wong AK, et al. Breed distribution and history of canine mdr1-1{increment}, a pharmacogenetic mutation that marks the emergence of breeds from the collie lineage. Proc Natl Acad Sci USA 2004;101:11725-11730.
28. Mealey KM. Therapeutic implications of the MDR-1 gene. J Vet Pharmacol Ther 2004;27:257-264.
29. Mealey KM, Bentjen SA, Waiting DK. Frequency of the mutant MDR1 allele associated with ivermectin sensitivity in a sample population of Collies from the northwestern United States. Am J Vet Res 2002;63:479-481.
30. Kwan P, Arzimanoglou A, Berg AT, et al. Definition of drug resistant epilepsy: Consensus proposal by the ad hoc Task Force of the ILAE Commission on Therapeutic Strategies. Epilepsia 2010;51:1069-1077.
31. Thomas WB. Idiopathic epilepsy in dogs. Vet Clin North Am Small Anim Pract 2000;30:183-206.
32. Weissl J, Hülsmeyer V, Brauer C, et al. Disease progression and treatment response of idiopathic epilepsy in Australian Shepherd dogs. J Vet Intern Med 2012;26:116-125.
33. Alves L, Hülsmeyer V, Jaggy A, et al. Polymorphisms in the ABCB1 gene in phenobarbital responsive and resistant idiopathic epileptic Border Collies. J Vet Intern Med 2011;25:484-489.
34. Haerian BS, Lim KS, Tan CT, et al. Association of ABCB1 gene polymorphisms and their haplotypes with response to antiepileptic drugs: A systematic review and meta-analysis. Pharmacogenomics 2011;12:713-725.
35. Löscher W, Luna-Tortós C, Römermann K, Fedrowitz M. Do ATP-binding cassette transporters cause pharmacoreistance in epilepsy? Problems and approaches in determining which antiepileptic drugs are affected. Curr Pharm Des 2011;17:2808-2828.
36. West CL, Mealey KL. Assessment of antiepileptic drugs as substrates for canine P-glycoprotein. Am J Vet Res 2007;68:1106-1110.
37. van Vliet EA, van Schaik R, Edelbroek PM, et al. Inhibition of the multidrug transporter P-glycoprotein improves seizure control in phenytoin-treated chronic epileptic rats. Epilepsia 2006;47:672-680.
38. Mealey KL, Greene S, Bagley R, et al. P-glycoprotein contributes to the blood-brain, but not blood-cerebrospinal fluid, barrier in a spontaneous canine p-glycoprotein knockout model. Drug Metab Dispos 2008;36:1073-1079.
39. Owen A, Pirmohamed M, Tettey JN, et al. Carbamazepine is not a substrate for P-glycoprotein. Br J Clin Pharmacol 2001;51:345-349.
40. Sills GJ, Kwan P, Butler E, et al. P-glycoprotein-mediated efflux of antiepileptic drugs: Preliminary studies in mdr1a knockout mice. Epilepsy Behav 2002;3:427-432.
41. Rogawski MA, Johnson MR. Intrinsic severity as a determinant of antiepileptic drug refractoriness. Epilepsy Curr 2008;8:127-130.
42. Handoko KB. Zwart-van Rijkom JE, Visee HF, et al. Drug treatment-related factors of inadequate seizure control. Epilepsy Behav 2008;13:545-548.
43. Kwan P, Brodie MJ. Early identification of refractory epilepsy. N Engl J Med 2000;342:314-319.
44. Schmidt D, Sillanpää M. Evidence-based review on the natural history of the epilepsies. Curr Opin Neurol 2012;25:159-163.
45. Hülsmeyer V, Zimmermann R, Brauer C, et al. Epilepsy in Border Collies: Clinical manifestation, outcome, and mode of inheritance. J Vet Intern Med 2010;24:171-178.